These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19957009)

  • 1. Multiple sclerosis attacks triggered by hyperprolactinemia.
    Nociti V; Frisullo G; Tartaglione T; Patanella AK; Iorio R; Tonali PA; Batocchi AP
    J Neurooncol; 2010 Jul; 98(3):407-9. PubMed ID: 19957009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prolactin level in patients with multiple sclerosis: a case control study.
    Harirchian MH; Sahraian MA; Shirani A
    Med Sci Monit; 2006 Apr; 12(4):CR177-80. PubMed ID: 16572053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis and hyperprolactinemia: a case-control study.
    Etemadifar M; Najafi MA; Najafi MR; Alavi A; Nasr Z; Farokhi M; Rezaei A
    Acta Neurol Belg; 2015 Sep; 115(3):253-7. PubMed ID: 25501283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenetic role of prolactinemia in multiple sclerosis].
    Golovkin VI; Mikhaĭlenko AA; Rakov AL
    Sov Med; 1991; (10):15-7. PubMed ID: 1801224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia in multiple sclerosis.
    Kira J; Harada M; Yamaguchi Y; Shida N; Goto I
    J Neurol Sci; 1991 Mar; 102(1):61-6. PubMed ID: 1906932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia in optico-spinal multiple sclerosis.
    Yamasaki K; Horiuchi I; Minohara M; Osoegawa M; Kawano Y; Ohyagi Y; Yamada T; Kira J
    Intern Med; 2000 Apr; 39(4):296-9. PubMed ID: 10801143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin level in patients with relapsing-remitting multiple sclerosis during relapse.
    Moshirzadeh S; Ghareghozli K; Harandi AA; Pakdaman H
    J Clin Neurosci; 2012 Apr; 19(4):622-3. PubMed ID: 22341909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of inflammation during multiple sclerosis.
    Ruiz F; Vigne S; Pot C
    Semin Immunopathol; 2019 Nov; 41(6):711-726. PubMed ID: 31732775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental triggers in multiple sclerosis. Fact or fallacy?
    Morrison W; Nelson J
    Axone; 1994 Sep; 16(1):23-6. PubMed ID: 7880765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
    Then Bergh F; Kümpfel T; Schumann E; Held U; Schwan M; Blazevic M; Wismüller A; Holsboer F; Yassouridis A; Uhr M; Weber F; Daumer M; Trenkwalder C; Auer DP
    BMC Neurol; 2006 May; 6():19. PubMed ID: 16719908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating prolactinoma can prevent autoimmune diseases.
    Watad A; Versini M; Jeandel PY; Amital H; Shoenfeld Y
    Cell Immunol; 2015 Apr; 294(2):84-6. PubMed ID: 25468803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: immune mechanism and update on current therapies.
    Bansil S; Cook SD; Rohowsky-Kochan C
    Ann Neurol; 1995 May; 37 Suppl 1():S87-101. PubMed ID: 8968220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy, effects on MRI and tolerability of weekly intramuscular interferon-beta-1a in patients with MS and CIS.
    Zivadinov R; Munschauer FE; Ramanathan M; Benedict RH; Weinstock-Guttman B
    Drugs Today (Barc); 2008 Aug; 44(8):601-13. PubMed ID: 18846271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Prolactin Levels in Multiple Sclerosis, Neuromyelitis Optica, and Clinically Isolated Syndrome Patients.
    Türkoğlu R; Giriş M; Gencer M; Akcan U; Örçen A
    Noro Psikiyatr Ars; 2016 Dec; 53(4):353-356. PubMed ID: 28360812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis - etiology and diagnostic potential.
    Kamińska J; Koper OM; Piechal K; Kemona H
    Postepy Hig Med Dosw (Online); 2017 Jun; 71(0):551-563. PubMed ID: 28665284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing clinical course of multiple sclerosis: a matter of gray matter.
    Calabrese M; Romualdi C; Poretto V; Favaretto A; Morra A; Rinaldi F; Perini P; Gallo P
    Ann Neurol; 2013 Jul; 74(1):76-83. PubMed ID: 23494723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurology. 4: Multiple sclerosis.
    Pender MP
    Med J Aust; 2000 Jun; 172(11):556-62. PubMed ID: 10920756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis update.
    Markowitz CE
    Am J Manag Care; 2013 Nov; 19(16 Suppl):s294-300. PubMed ID: 24494618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Based Differences in Multiple Sclerosis (Part I): Biology of Disease Incidence.
    Dunn SE; Lee H; Pavri FR; Zhang MA
    Curr Top Behav Neurosci; 2015; 26():29-56. PubMed ID: 25690593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation.
    Ricigliano VAG; Morena E; Colombi A; Tonietto M; Hamzaoui M; Poirion E; Bottlaender M; Gervais P; Louapre C; Bodini B; Stankoff B
    Radiology; 2021 Oct; 301(1):166-177. PubMed ID: 34254858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.